<DOC>
	<DOCNO>NCT00753051</DOCNO>
	<brief_summary>Clozapine treatment resistant schizophrenia still prevalent.The effectiveness augment clozapine : one augment haloperidol electroconvulsive therapy determined.This study randomize control trial .</brief_summary>
	<brief_title>Treat Clozapine ( CLZ ) -Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy ( ECT )</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>1. schizophrenic patient diagnose schedule clinical assessment neuropsychiatry ( SCAN ) accordance DSMIVTR ICD10 2 . Resistant least 6 week clozapine treatment therapeutic dosage 3 . Voluntary participate research protocol express signing informed consent form 1 . Patient volunteer 2 . Patient epilepsy , DM , cardiac disease , autistic disorder illiterate 3 . Patient deaf , blind , dumb obstruct good communication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>clozapine-resistant schizophrenic</keyword>
	<keyword>haloperidol augment clozapine</keyword>
	<keyword>electroconvulsive therapy augment clozapine</keyword>
</DOC>